16-Apr-2025 1:02 PM CST - Yahoo Finance CRISPR Therapeutics (NasdaqGM:CRSP) Sees 25% Price Increase Over Last Week CRISPR Therapeutics (NasdaqGM:CRSP) witnessed a notable 25% gain over the past week, gaining traction amid an executive departure. The announcement of COO Julianne Bruno's exit could have influenced investor sentiment,
11-Apr-2025 2:45 AM CST - The Motley Fool Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it's commercialized several products. CRISPR Therapeutics won its first regulatory approval a little over a year ago,
5-Apr-2025 1:34 PM CST - Yahoo Finance CRISPR Therapeutics (NasdaqGM:CRSP) Sees 12% Weekly Dip Following COO Resignation CRISPR Therapeutics (NasdaqGM:CRSP) experienced an 12% price decline over the last week, coinciding with significant market disruption driven by escalating tariff tensions, which saw the S&P 500 and Nasdaq drop 10% and 11%,
2-Apr-2025 3:01 PM CST - Seeking Alpha CRISPR Therapeutics snaps six straight sessions of losses CRISPR Therapeutics (NASDAQ:CRSP) shares snapped six straight sessions of losses on Wednesday, as the stock closed 3% to $34.18. The Switzerland-based biotech company lost about 19% in the preceding six sessions.
2-Apr-2025 1:29 PM CST - Seeking Alpha CRISPR Therapeutics set to snap six straight sessions of losses CRISPR Therapeutics ( NASDAQ: CRSP) shares were on track to snap six straight sessions of losses on Wednesday, as the stock rose over 2% to $34.03 in afternoon trade.
26-Mar-2025 3:01 PM CST - Yahoo Finance CRISPR Therapeutics Announces Transition of Chief Operating Officer CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that its Chief Operating Officer, Julianne Bruno,
26-Mar-2025 5:33 AM CST - Yahoo Finance This CRISPR Therapeutics Insider Increased Their Holding In The Last Year Insiders were net buyers of CRISPR Therapeutics AG's (NASDAQ:CRSP ) stock during the past year. That is, insiders bought more stock than they sold. Although we don't think shareholders should simply follow insider transactions,
16-Apr-2025 1:02 PM CST - Yahoo Finance CRISPR Therapeutics (NasdaqGM:CRSP) Sees 25% Price Increase Over Last Week CRISPR Therapeutics (NasdaqGM:CRSP) witnessed a notable 25% gain over the past week, gaining traction amid an executive departure. The announcement of COO Julianne Bruno's exit could have influenced investor sentiment,
11-Apr-2025 2:45 AM CST - The Motley Fool Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it's commercialized several products. CRISPR Therapeutics won its first regulatory approval a little over a year ago,
5-Apr-2025 1:34 PM CST - Yahoo Finance CRISPR Therapeutics (NasdaqGM:CRSP) Sees 12% Weekly Dip Following COO Resignation CRISPR Therapeutics (NasdaqGM:CRSP) experienced an 12% price decline over the last week, coinciding with significant market disruption driven by escalating tariff tensions, which saw the S&P 500 and Nasdaq drop 10% and 11%,
2-Apr-2025 3:01 PM CST - Seeking Alpha CRISPR Therapeutics snaps six straight sessions of losses CRISPR Therapeutics (NASDAQ:CRSP) shares snapped six straight sessions of losses on Wednesday, as the stock closed 3% to $34.18. The Switzerland-based biotech company lost about 19% in the preceding six sessions.
2-Apr-2025 1:29 PM CST - Seeking Alpha CRISPR Therapeutics set to snap six straight sessions of losses CRISPR Therapeutics ( NASDAQ: CRSP) shares were on track to snap six straight sessions of losses on Wednesday, as the stock rose over 2% to $34.03 in afternoon trade.
26-Mar-2025 3:01 PM CST - Yahoo Finance CRISPR Therapeutics Announces Transition of Chief Operating Officer CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that its Chief Operating Officer, Julianne Bruno,
26-Mar-2025 5:33 AM CST - Yahoo Finance This CRISPR Therapeutics Insider Increased Their Holding In The Last Year Insiders were net buyers of CRISPR Therapeutics AG's (NASDAQ:CRSP ) stock during the past year. That is, insiders bought more stock than they sold. Although we don't think shareholders should simply follow insider transactions,
